Pereira S, Black C, Welsh K, Ansell B, Jayson M, Maddison P, Rowell N
Department of Rheumatology, West Middlesex Hospital, London, United Kingdom.
J Rheumatol. 1987 Aug;14(4):760-5.
Clinical and serological evidence of connective tissue disease was found in a high proportion of 132 family members of 30 patients with systemic sclerosis. In 20 probands with the milder CREST form of the disease, 10 had HLA-DR5 and 12 had null alleles at the C4 loci. None of 11 probands with more severe systemic sclerosis had HLA-DR5; all 11 had null alleles at the C4 loci. All but two of the probands had either HLA-DR5 or a C4 null allele, and this was also the case for the majority of the relatives with autoantibodies. Genetic markers of the major histocompatibility complex, including HLA-DR5 and C4 null alleles, appear to be closely associated with markers of disease in these probands and their families.
在30例系统性硬化症患者的132名家庭成员中,很大一部分发现了结缔组织病的临床和血清学证据。在20例患有病情较轻的CREST型疾病的先证者中,10例有HLA-DR5,12例在C4位点有无效等位基因。11例患有更严重系统性硬化症的先证者均无HLA-DR5;11例在C4位点均有无效等位基因。除两名先证者外,所有先证者均有HLA-DR5或C4无效等位基因,大多数有自身抗体的亲属也是如此。主要组织相容性复合体的遗传标记,包括HLA-DR5和C4无效等位基因,似乎与这些先证者及其家族中的疾病标记密切相关。